Literature DB >> 2006148

Corticosterone levels determine individual vulnerability to amphetamine self-administration.

P V Piazza1, S Maccari, J M Deminière, M Le Moal, P Mormède, H Simon.   

Abstract

Individual vulnerability to the reinforcing properties of drugs appears to be an essential characteristic predisposing humans to addiction. In animals, a greater behavioral reactivity to a mild stress, such as exposure to a novel environment, is an index of the vulnerability to acquire amphetamine self-administration. Biological responses to stress as well as behavioral reactivity may predict such a vulnerability. In the present study, rats with a longer duration of corticosterone secretion after exposure to novelty showed facilitation of acquisition of amphetamine self-administration. Furthermore, corticosterone administration in nonpredisposed individuals increased the reinforcing value of the drug and facilitated the acquisition of amphetamine self-administration. These results indicate that the stress-related activity of the hypothalamic-pituitary-adrenal axis may play a role in the pathogenesis of psychostimulant addiction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2006148      PMCID: PMC51174          DOI: 10.1073/pnas.88.6.2088

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Urinary free cortisol in psychotic depression.

Authors:  R F Anton
Journal:  Biol Psychiatry       Date:  1987-01       Impact factor: 13.382

2.  Individual differences in the reinforcing and subjective effects of amphetamine and diazepam.

Authors:  H de Wit; E H Uhlenhuth; C E Johanson
Journal:  Drug Alcohol Depend       Date:  1986-02       Impact factor: 4.492

3.  Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.

Authors:  B E Murphy
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

Review 4.  The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

Authors:  R M Sapolsky; L C Krey; B S McEwen
Journal:  Endocr Rev       Date:  1986-08       Impact factor: 19.871

5.  Increased sensitivity to (+)amphetamine self-administered by rats following meso-cortico-limbic dopamine neurone destruction.

Authors:  M Le Moal; L Stinus; H Simon
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

6.  Restrained rats learn amphetamine-conditioned locomotion, but not place preference.

Authors:  N R Swerdlow; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Interchangeability of stress and amphetamine in sensitization.

Authors:  S M Antelman; A J Eichler; C A Black; D Kocan
Journal:  Science       Date:  1980-01-18       Impact factor: 47.728

8.  Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration.

Authors:  P V Piazza; J M Deminiere; M le Moal; H Simon
Journal:  Brain Res       Date:  1990-04-23       Impact factor: 3.252

Review 9.  Corticosteroid inhibition of ACTH secretion.

Authors:  M E Keller-Wood; M F Dallman
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

Review 10.  Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis.

Authors:  T E Robinson; J B Becker
Journal:  Brain Res       Date:  1986-06       Impact factor: 3.252

View more
  127 in total

1.  Vertical shifts in self-administration dose-response functions predict a drug-vulnerable phenotype predisposed to addiction.

Authors:  P V Piazza; V Deroche-Gamonent; F Rouge-Pont; M Le Moal
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

2.  Fear of novelty in infant rats predicts adult corticosterone dynamics and an early death.

Authors:  S A Cavigelli; M K McClintock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

3.  Neonatal isolation enhances maintenance but not reinstatement of cocaine self-administration in adult male rats.

Authors:  Xiang Yang Zhang; Hayde Sanchez; Priscilla Kehoe; Therese A Kosten
Journal:  Psychopharmacology (Berl)       Date:  2004-07-16       Impact factor: 4.530

Review 4.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

Review 5.  Potential programming of dopaminergic circuits by early life stress.

Authors:  Ana-João Rodrigues; Pedro Leão; Miguel Carvalho; Osborne F X Almeida; Nuno Sousa
Journal:  Psychopharmacology (Berl)       Date:  2010-11-19       Impact factor: 4.530

Review 6.  Developmental pathology, dopamine, stress and schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Int J Dev Neurosci       Date:  2010-08-19       Impact factor: 2.457

7.  High novelty-seeking rats are resilient to negative physiological effects of the early life stress.

Authors:  Sarah M Clinton; Stanley J Watson; Huda Akil
Journal:  Stress       Date:  2013-11-06       Impact factor: 3.493

8.  Effect of adrenalectomy on the initiation and expression of cocaine-induced sensitization.

Authors:  B M Prasad; C Ulibarri; P W Kalivas; B A Sorg
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

9.  Consequence of long-term exposure to corticosterone or dexamethasone on ethanol consumption in the adrenalectomized rat, and the effect of type I and type II corticosteroid receptor antagonists.

Authors:  C Fahlke; E Hård; C J Eriksson; J A Engel; S Hansen
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

10.  Strain differences in the rewarding and dopamine-releasing effects of morphine in rats.

Authors:  M Shoaib; R Spanagel; T Stohr; T S Shippenberg
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.